Exchange Traded Concepts, LLC Novo Cure LTD Transaction History

Exchange Traded Concepts, LLC

  • $4.74 Billion
  • Q4 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 28,811 shares of NVCR stock, worth $758,593. This represents 0.02% of its overall portfolio holdings.

Number of Shares
28,811
Previous 48,427 40.51%
Holding current value
$758,593
Previous $756,000 13.49%
% of portfolio
0.02%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
SELL
$14.54 - $33.41 $285,216 - $655,370
-19,616 Reduced 40.51%
28,811 $858,000
Q3 2024

Oct 10, 2024
BUY
$15.61 - $23.34 $129,125 - $193,068
8,272 Added 20.6%
48,427 $756,000
Q2 2024

Aug 13, 2024
SELL
$11.83 - $24.05 $222,108 - $451,538
-18,775 Reduced 31.86%
40,155 $687,000
Q1 2024

Apr 15, 2024
SELL
$12.42 - $17.29 $184,176 - $256,393
-14,829 Reduced 20.1%
58,930 $921,000
Q4 2023

Jan 05, 2024
BUY
$11.13 - $15.78 $251,838 - $357,054
22,627 Added 44.25%
73,759 $1.1 Million
Q3 2023

Oct 18, 2023
BUY
$16.15 - $42.35 $553,767 - $1.45 Million
34,289 Added 203.58%
51,132 $825,000
Q2 2023

Jul 20, 2023
SELL
$40.29 - $82.51 $39,605 - $81,107
-983 Reduced 5.51%
16,843 $698,000
Q1 2023

Apr 12, 2023
SELL
$56.44 - $118.81 $16,875 - $35,524
-299 Reduced 1.65%
17,826 $1.07 Million
Q4 2022

Jan 17, 2023
BUY
$63.98 - $85.37 $23,544 - $31,416
368 Added 2.07%
18,125 $1.33 Million
Q3 2022

Oct 07, 2022
SELL
$67.99 - $89.57 $278,011 - $366,251
-4,089 Reduced 18.72%
17,757 $1.35 Million
Q2 2022

Jul 20, 2022
SELL
$56.6 - $89.9 $576,697 - $915,991
-10,189 Reduced 31.81%
21,846 $1.52 Million
Q1 2022

Apr 26, 2022
SELL
$60.15 - $84.52 $169,983 - $238,853
-2,826 Reduced 8.11%
32,035 $2.65 Million
Q4 2021

Jan 13, 2022
BUY
$75.08 - $121.99 $1.58 Million - $2.56 Million
20,985 Added 151.23%
34,861 $2.62 Million
Q3 2021

Oct 18, 2021
BUY
$116.17 - $194.55 $373,486 - $625,478
3,215 Added 30.16%
13,876 $1.61 Million
Q2 2021

Jul 30, 2021
SELL
$130.4 - $225.58 $326,652 - $565,077
-2,505 Reduced 19.03%
10,661 $2.37 Million
Q1 2021

Apr 20, 2021
BUY
$124.11 - $190.17 $724,430 - $1.11 Million
5,837 Added 79.64%
13,166 $1.74 Million
Q4 2020

Jan 19, 2021
SELL
$112.16 - $174.14 $223,983 - $347,757
-1,997 Reduced 21.41%
7,329 $1.27 Million
Q3 2020

Oct 30, 2020
BUY
$58.05 - $111.31 $190,520 - $365,319
3,282 Added 54.3%
9,326 $1.04 Million
Q2 2020

Jul 15, 2020
BUY
$57.2 - $74.41 $249,964 - $325,171
4,370 Added 261.05%
6,044 $358,000
Q1 2020

Apr 14, 2020
BUY
$57.05 - $95.75 $62,926 - $105,612
1,103 Added 193.17%
1,674 $113,000
Q4 2019

Jan 22, 2020
BUY
$68.3 - $93.8 $38,999 - $53,559
571 New
571 $48,000

Others Institutions Holding NVCR

# of Institutions
263
Shares Held
76.9M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.76B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email